Table 7.
Multivariate regression | Mobility | Self-care | Usual activities | Pain/discomfort | Anxiety/depression | VAS | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Effect | SE | p-value | Effect | SE | p-value | Effect | SE | p-value | Effect | SE | p-value | Effect | SE | p-value | Effect | SE | p-value | ||
Non-progressed | |||||||||||||||||||
Gender | |||||||||||||||||||
Female (ref.) | |||||||||||||||||||
Male | −0.090 | 0.079 | 0.5118 | −0.040 | 0.074 | 1.171 | 0.085 | 0.094 | 0.7234 | −0.030 | 0.063 | 1.2604 | −0.043 | 0.068 | 1.0436 | −0.295 | 1.612 | 1.7096 | |
Age | 0.021 | 0.003 | <0.001 | 0.012 | 0.003 | <0.001 | 0.014 | 0.004 | <0.001 | 0.000 | 0.002 | 1.9988 | 0.000 | 0.003 | 1.9844 | −0.150 | 0.061 | 0.0278 | |
Current treatment | |||||||||||||||||||
TTFields only | |||||||||||||||||||
TTFields + others | 0.127 | 0.079 | 0.218 | 0.167 | 0.074 | 0.0466 | 0.199 | 0.093 | 0.0656 | 0.139 | 0.062 | 0.0512 | 0.039 | 0.067 | 1.1294 | −3.796 | 1.600 | 0.0354 | |
Time since diagnosis | 0.005 | 0.002 | 0.0082 | 0.004 | 0.002 | 0.0338 | 0.001 | 0.002 | 1.0682 | 0.003 | 0.001 | 0.1172 | 0.001 | 0.002 | 1.411 | −0.002 | 0.036 | 1.8988 | |
Gender | |||||||||||||||||||
Female (ref.) | |||||||||||||||||||
Male | −0.091 | 0.079 | 0.5064 | −0.040 | 0.074 | 1.1836 | 0.086 | 0.094 | 0.7212 | −0.030 | 0.063 | 1.2592 | −0.043 | 0.068 | 1.053 | −0.305 | 1.612 | 1.6994 | |
Age | 0.021 | 0.003 | <0.001 | 0.011 | 0.003 | <0.001 | 0.014 | 0.004 | <0.001 | 0.000 | 0.002 | 1.8524 | 0.000 | 0.003 | 1.937 | −0.150 | 0.061 | 0.0282 | |
Current treatment | |||||||||||||||||||
TTFields only | |||||||||||||||||||
TTFields + others | 0.177 | 0.085 | 0.0762 | 0.183 | 0.080 | 0.0428 | 0.197 | 0.100 | 0.1 | 0.164 | 0.067 | 0.0296 | 0.027 | 0.073 | 1.4222 | −3.593 | 1.726 | 0.0748 | |
Log(Time since diagnosis) | 0.165 | 0.059 | 0.0106 | 0.092 | 0.055 | 0.191 | 0.018 | 0.070 | 1.5838 | 0.084 | 0.047 | 0.144 | −0.009 | 0.050 | 1.7116 | 0.288 | 1.198 | 1.6204 | |
Progressed | |||||||||||||||||||
Gender | |||||||||||||||||||
Female (ref.) | |||||||||||||||||||
Male | 0.064 | 0.173 | 1.426 | 0.121 | 0.179 | 0.9986 | 0.236 | 0.168 | 0.3204 | −0.098 | 0.121 | 0.8362 | −0.120 | 0.114 | 0.5812 | −1.431 | 3.102 | 1.2894 | |
Age | 0.023 | 0.007 | 0.0036 | 0.017 | 0.008 | 0.056 | 0.021 | 0.007 | 0.0072 | −0.006 | 0.005 | 0.4914 | −0.003 | 0.005 | 1.0734 | −0.272 | 0.132 | 0.0778 | |
Current treatment | |||||||||||||||||||
TTFields only | |||||||||||||||||||
TTFields + others | −0.165 | 0.178 | 0.709 | −0.167 | 0.186 | 0.7382 | −0.136 | 0.175 | 0.8748 | 0.123 | 0.127 | 0.6668 | 0.009 | 0.118 | 1.878 | 4.662 | 3.232 | 0.2984 | |
Time since diagnosis | −0.005 | 0.003 | 0.113 | −0.007 | 0.003 | 0.0158 | −0.006 | 0.003 | 0.047 | −0.002 | 0.002 | 0.6616 | −0.002 | 0.002 | 0.445 | 0.164 | 0.050 | 0.002 | |
Gender | |||||||||||||||||||
Female (ref.) | |||||||||||||||||||
Male | 0.085 | 0.171 | 1.2402 | 0.152 | 0.177 | 0.7806 | 0.258 | 0.166 | 0.2408 | −0.083 | 0.121 | 0.9828 | −0.106 | 0.113 | 0.6928 | −2.365 | 3.105 | 0.8928 | |
Age | 0.023 | 0.007 | 0.0038 | 0.017 | 0.008 | 0.0602 | 0.021 | 0.007 | 0.0078 | −0.006 | 0.005 | 0.5102 | −0.003 | 0.005 | 1.0894 | −0.271 | 0.133 | 0.0846 | |
Current treatment | |||||||||||||||||||
TTFields only | |||||||||||||||||||
TTFields + others | −0.218 | 0.182 | 0.4656 | −0.239 | 0.190 | 0.4174 | −0.200 | 0.179 | 0.5264 | 0.135 | 0.130 | 0.6012 | 0.006 | 0.122 | 1.9194 | 5.110 | 3.340 | 0.252 | |
Log(Time since diagnosis) | −0.222 | 0.105 | 0.0694 | −0.320 | 0.109 | 0.007 | −0.271 | 0.103 | 0.0162 | −0.013 | 0.075 | 1.7214 | −0.053 | 0.070 | 0.9108 | 4.708 | 1.967 | 0.0334 |
Entries with light shading denote statistically significant deterioration, while those with dark shading indicate statistically significant improvement. Within the EQ-5D subscales (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), lower scores indicate less impairment and higher scores more impairment in health-related quality of life (HRQoL). For EQ-VAS, higher values indicate improved self-rated health and lower values indicate worse self-rated health. Quoted p-values = raw p-vales × 2 to adjust for multiple comparisons.
VAS, visual analogue scale; TTFields, tumor treating fields.